Welcome to our dedicated page for Allstate SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation (NYSE: ALL) files a range of documents with the U.S. Securities and Exchange Commission, and this page aggregates those SEC filings for ALL with AI-powered summaries. As a public property and casualty insurer, Allstate uses Form 8-K to report material events such as monthly catastrophe loss estimates, Allstate Protection policies in force, quarterly earnings results, dividend declarations and certain governance changes.
Recent Form 8-K filings show Allstate furnishing monthly releases on catastrophe losses and policy counts for auto, homeowners, other personal lines and commercial lines. These exhibits, referenced under Regulation FD, provide detail on estimated catastrophe losses for specific months and tables of policies in force. Other 8-K filings furnish quarterly earnings press releases and investor supplements, giving investors access to the company’s results of operations and financial condition.
Allstate’s filings also list its registered securities under Section 12(b) of the Exchange Act, including common stock (ALL) and several listed instruments such as 5.100% Fixed-to-Floating Rate Subordinated Debentures due 2053 (ALL.PR.B) and depositary shares representing preferred stock series H, I and J. Filings may also disclose board and governance developments, such as changes in lead director roles and director retirements.
On this SEC filings page, users can review Allstate’s Form 8-K disclosures and, where available, other core filings like annual reports on Form 10-K, quarterly reports on Form 10-Q and proxy statements. AI-generated highlights help explain the key points of lengthy documents, making it easier to understand topics such as catastrophe impacts, policy trends, capital structure and corporate actions without reading every page.
Investors interested in ALL SEC filings can use this resource to track new submissions as they appear on EDGAR, quickly scan AI summaries for each filing and drill into the full text when deeper analysis is needed.
ALLSTATE CORP executive Mark Q. Prindiville reported equity compensation activity involving company common stock. He acquired 7,233 shares at no cost through the conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan. To cover related tax withholding obligations, 2,513 shares were disposed of at a price of $207.51 per share. After these transactions, he directly owned 26,994 common shares, a net increase of 4,720 shares.
Allstate Corp executive Elizabeth Brady reported equity compensation activity involving company common stock. She acquired 8,912 shares of common stock on
On the same date, 3,256 shares were disposed of at a price of
Allstate Corp filed a Form 13F reporting its institutional equity holdings. The report lists 699 information-table entries with an aggregate value of $7,320,757,738. The filing shows 2 other included managers: Allstate Investment Management Co and Allstate Investments LLC. The report is signed by Alexandra Band, Senior Vice President & CFO Investment Finance, dated 02-06-2026.
The Allstate Corporation executive Christine M. DeBiase reported routine equity compensation activity in company stock. On February 3, 2026, previously awarded restricted stock units converted into 2,538 shares of Allstate common stock at $0 exercise price under the 2019 Equity Incentive Plan. To cover tax withholding, 1,071 shares of common stock were withheld or disposed of at a price of $201.77 per share. After these transactions, DeBiase directly owned 5,191.904 shares of Allstate common stock.
The Allstate Corporation Chairman, President and CEO Thomas J. Wilson reported multiple open-market sales of Allstate common stock on February 2, 2026. The transactions, coded as sales, covered blocks of 1,605, 1,572, 13,271 and 359 shares at weighted average prices between $198.7714 and $201.5107, with actual trade prices ranging from $198.23 to $201.655.
These sales were executed under a Rule 10b5-1 trading plan adopted on June 27, 2025. After the reported sales, Wilson directly owned 77,601.303 Allstate common shares and also had indirect beneficial holdings through several GRATs, a 401(k) plan, and a remainder trust.
The Allstate Corporation filed a current report to furnish its press release announcing financial results for the fourth quarter and full year of 2025. The company also furnished a fourth quarter 2025 investor supplement, both as exhibits to the report, providing more detailed financial and operating information.
Allstate Corporation director Monica J. Turner reported an equity award transaction. On 02/01/2026, 456 restricted stock units converted into 456 shares of Allstate common stock at a price of $0.00 per share under the 2017 Equity Compensation Plan for Non-Employee Directors.
Following the conversion, Turner directly owns 456 shares of Allstate common stock and no longer holds the 456 restricted stock units, reflecting a shift from derivative to outright share ownership rather than a market sale or purchase.
The Allstate Corporation filed a Form 8-K to inform investors that its December 2025 monthly release is available. This release provides estimated catastrophe losses and the number of policies in force, giving insight into recent claims activity and current insurance exposure.
The company states that the release is posted on allstateinvestors.com and is also included as Exhibit 99 to this report. The exhibit is furnished, not filed, under Regulation FD, meaning it is meant for broad public disclosure rather than updating certain legal filings.
The Allstate Corporation’s Chairman, President & CEO Thomas J. Wilson reported multiple open-market sales of company common stock on January 12, 2026. Across several trades coded as sales, he sold a total of 16,807 shares at weighted average prices ranging from $205.6779 to $209.9939, with actual sale prices spanning from $205.30 to $210.42.
The filing notes that these transactions were carried out under a Rule 10b5-1 trading plan adopted on June 27, 2025, indicating they were pre-arranged. Following the reported sales, Wilson directly beneficially owns 94,408.303 shares of Allstate common stock. He also reports indirect holdings, including 31,900 shares held by a 2024-C GRAT and 69,822 shares held by a 2025-A GRAT, along with additional trust and plan positions.
Allstate Corporation executive Suren Gupta, President, Enterprise Solutions, reported an employee stock option exercise and related stock sale. On January 7, 2026, he exercised an employee stock option for 19,593 shares of Allstate common stock at an exercise price of $62.32 per share and acquired the underlying shares. On the same date, he reported selling 19,593 shares of Allstate common stock at a reported price of $210 per share.
After these transactions, Gupta directly owned 100,646 shares of Allstate common stock. He also had indirect holdings of 1,335 shares through a 401(k) plan and 7 shares through VVG Holdings LLC.